Hemolitik anemili çocukta sevofluran anestezisi sonrası akut hepatit

Herediter sferositoz, eritrosit membranındaki defektler sonucu hemolitik anemiye neden olan kalıtsal bir kan hastalığıdır. Herediter sferositozlu çocuklarda intraoperatif dönemde masif hemoliz olduğuna dair literatürde herhangi bir veri olmamasına rağmen, hemolize bağlı sekonder organ hasarını önlemek için dikkatli olunmalıdır. Herediter sferositozlu 6 yaşındaki çocukta hipospadias onarımı sonrası darlık geliştiğinden meatotomi planlanmaktaydı. Anestezi idamesinde sevofluran kullanılan hastada, perioperatif dönemde hemolize bağlı herhangi bir komplikasyon oluşmadı. Ancak operasyonun ertesi günü karaciğer enzimlerinde belirgin yükselme ve hepatomegali saptandı. Anestezi sonrasında oluşan bu karaciğer hasarının sevoflurana bağlı olduğu düşünüldü. Ancak viral seroloji sonuçları geldiğinde hastanın Hepatit A virüs enfeksiyonu geçirdiği anlaşıldı.

Acute hepatitis after sevoflurane anesthesia in a child with hemolytic anemia

Hereditary spherocytosis is a genetically determined red blood cell membrane disorder that results in hemolytic anemia. Despite the fact that there are no previous reports of massive or increased intraoperative hemolysis in children with hereditary spherocytosis, we should nevertheless take precautions to prevent secondary organ failure caused by hemolysis. A 6-y'ears-old child with hereditary spherocytosis was scheduled for a meatotomy procedure due to complication of hipospadias repair. Sevoflurane was used during maintenance of anesthesia and no serious complications as a result of hemolysis occured in the perioperative period. However, the day after operation, a considerable increase in liver enzymes was observed and hepatomegaly was diagnosed. It was thought that this liver injury caused by sevoflurane exposure, but after the viral serology, concomitant Hepatitis A virus infection was detected.

___

  • 1. Bolton-Maggs PH. Hereditary spherocytosis; new guidelines. Arch Dis Child 2004; 89: 809-12.
  • 2. Bolton-Maggs PH, Stevens RF, Dodd NJ ve ark. Guidelines for the diagnosis and management of hereditary spherocytosis. Br J Haematol 2004; 126: 455-74.
  • 3. Yoshimura N, Murakami H, Otaka S ve ark. Open heart operation in a child with congenital heart disease and hereditary spherocytosis. Circ J 2006; 70: 1655-7.
  • 4. Kharasch ED. Biotransformation of sevoflurane. Anesth Analg 1995; 81: S27-38.
  • 5. Kharasch ED, Armstrong AS, Gunn K, Artru A, Cox K, Karol MD. Clinical sevoflurane metabolism and disposition. II. The role of cytochrome P450 2E1 in fluoride and hexafluoroisopropanol formation. Anesthesiology 1995; 82: 1379-88.
  • 6. Reich A, Everding AS, Bulla M, Brinkmann OA, Van Aken H. Hepatitis after sevoflurane exposure in an infant suffering from primary hyperoxaluria type 1. Anesth Analg 2004; 99: 370-2.
  • 7. Nishiyama T, Yokoyama T, Hanaoka K. Liver function after sevoflurane or isoflurane anaesthesia in neurosurgical patients. Can J Anaesth 1998; 45: 753-6.
  • 8. Bruun LS, Elkjaer S, Bitsch-Larsen D, Anderson O. Hepatic failure in a child after acetaminophen and sevoflurane exposure. Anesth Analg 2001; 92: 1446-8.
  • 9. Martin JL. Volatile anesthetics and liver injury: a clinical update or what every anesthesiologist should know. Can J Anaesth 2005; 52: 125-9.